Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03723525
What this trial is testing

Package of Care to Improve Retention in ART and Mortality Among Treatment Naive HIV Infected Individuals

Who this might be right for
HIV
National Centre for AIDs and STD Control, Nepal 1,073
Early research (Phase 1)Ended earlyNCT01081808
What this trial is testing

Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors

Who this might be right for
NeoplasmsTumorsSolid Tumors+1 more
Roger Williams Medical Center 2
Large-scale testing (Phase 3)Study completedNCT00102960
What this trial is testing

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 377
Not applicableStudy completedNCT00038259
What this trial is testing

Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 21
Not applicableLooking for participantsNCT07772791
What this trial is testing

Online Cohort of Sexual and Gender Minorities: Evaluating Digital Interventions to Improve HIV Pre-Exposure Prophylaxis and Antiretroviral Treatment Uptake and Adherence

Who this might be right for
HIV Infections
Oswaldo Cruz Foundation 3,000
Large-scale testing (Phase 3)Study completedNCT01011413
What this trial is testing

Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults.

Who this might be right for
HIV Infections
Kirby Institute 636
Not applicableActive Not RecruitingNCT07370298
What this trial is testing

Developing and Testing a Digital Health Tool for INterseCtional Stigma Assessment and Reduction at Multiple Levels and mUltiple DimEnsions (INCLUDE) to Improve HIV Care in ART Centers in Nepal

Who this might be right for
HIV Care Loss to FollowupHIV Antiretroviral Therapy (ART) AdherenceHIV Stigma+5 more
Possible 88
Not applicableUnknownNCT02674867
What this trial is testing

CLEAC (Comparison of Late Versus Early Antiretroviral Therapy in HIV-infected Children)

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 80
Not applicableEnded earlyNCT02641444
What this trial is testing

Antiretroviral Localization in Gut-Associated Lymphoid Tissue and Lower Female Genital Tract Tissue of HIV+ Subjects

Who this might be right for
HIV
University of North Carolina, Chapel Hill 5
Not applicableStudy completedNCT00776412
What this trial is testing

Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults

Who this might be right for
InflammationPathologic Processes
National Institute of Allergy and Infectious Diseases (NIAID) 310
Not applicableLooking for participantsNCT07226128
What this trial is testing

The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV

Who this might be right for
HIVDepression in AdultsInsulin Resistance+1 more
Indiana University 150
Not applicableStudy completedNCT06056037
What this trial is testing

Making ART Work Among Brazilian Youth

Who this might be right for
HivAdherence, Medication
Brown University 30
Not applicableNot Yet RecruitingNCT07116538
What this trial is testing

Implementation and Effects of Nishauri on HIV Treatment Outcomes Among Men

Who this might be right for
HIV Antiretroviral Therapy (ART) Adherence
Maseno University 347
Post-approval studies (Phase 4)WithdrawnNCT04183738
What this trial is testing

Inflammation and Co-Infections in D²EFT

Who this might be right for
HIV-infection/AidsHuman Herpesvirus 4 InfectionsCytomegalovirus Infections+2 more
Kirby Institute
Large-scale testing (Phase 3)Study completedNCT02227238
What this trial is testing

Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment

Who this might be right for
HIV Infections
ViiV Healthcare 627
Post-approval studies (Phase 4)Study completedNCT00646984
What this trial is testing

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Hospital Clinic of Barcelona 147
Post-approval studies (Phase 4)Not Yet RecruitingNCT06375304
What this trial is testing

The Antiretroviral Speed Access Program Switch (ASAP-Switch) Study

Who this might be right for
HIV Infections
McGill University Health Centre/Research Institute of the McGill University Health Centre 50
Testing effectiveness (Phase 2)Looking for participantsNCT05586581
What this trial is testing

SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy

Who this might be right for
HIV Associated Neurocognitive DisorderHIV DementiaHIV Encephalitis+1 more
Yale University 70
Not applicableStudy completedNCT02196064
What this trial is testing

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."

Who this might be right for
Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects
Fundación Pública Andaluza Progreso y Salud 519
Large-scale testing (Phase 3)Study completedNCT02285114
What this trial is testing

Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2-Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen

Who this might be right for
HIV-1
Gilead Sciences 41
Next Page